Ignite Creation Date:
2024-05-06 @ 9:28 AM
Last Modification Date:
2024-10-26 @ 12:15 PM
Study NCT ID:
NCT02991677
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-21
First Post:
2016-11-30
Brief Title:
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
Sponsor:
Baltimore VA Medical Center
Organization:
Baltimore VA Medical Center
Study Overview
Official Title:
Exercise Effect on Chemotherapy-Induced Neuropathic Pain Peripheral Nerve Fibers
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Chemotherapy-induced peripheral neuropathy CIPN continues to be a serious healthcare concern It is painful persistent resistant to conventional pain therapies and results in long-term suffering and decreased quality of life for many cancer survivors The role of exercise to decrease CIPN-related neuropathic pain CIPN-NP will be investigated with the goal of identifying the mechanisms associated with this therapeutic approach to manage CIPN-NP
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None